General Information of the Compound
Compound ID |
CP0946114
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
(S)-N1-((2S,5S,8S,11S,14S)-11-((1H-indol-3-yl)methyl)-1-amino-8-(4-aminobutyl)-5-(4-hydroxybenzyl)-2-(hydroxymethyl)-15-(1H-indol-3-yl)-1,4,7,10,13-pentaoxo-3,6,9,12-tetraazapentadecan-14-yl)-2-aminosuccinamide
Show/Hide
|
||||||||||||||||||
Formula |
C44H55N11O9
|
||||||||||||||||||
Molecular Weight |
881.992
|
||||||||||||||||||
Canonical SMILES |
NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(N)=O
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C44H55N11O9/c45-16-6-5-11-33(41(61)53-34(17-24-12-14-27(57)15-13-24)42(62)55-37(23-56)39(48)59)51-43(63)36(19-26-22-50-32-10-4-2-8-29(26)32)54-44(64)35(52-40(60)30(46)20-38(47)58)18-25-21-49-31-9-3-1-7-28(25)31/h1-4,7-10,12-15,21-22,30,33-37,49-50,56-57H,5-6,11,16-20,23,45-46H2,(H2,47,58)(H2,48,59)(H,51,63)(H,52,60)(H,53,61)(H,54,64)(H,55,62)/t30-,33-,34-,35-,36-,37-/m0/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
RRFIGBGLRVMLOK-BPAOWUMVSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound